IQM Quantum Computers to Deliver Czech Republic’s First Quantum Computer With Unique Star Topology
26.9.2024 11:00:00 CEST | Business Wire | Press Release
IQM Quantum Computers (IQM), a global leader in designing, building, and selling superconducting quantum computers, today announced the company has won a contract to deliver the Czech Republic’s first quantum computer to be installed at the IT4Innovations National Supercomputing Centre in Ostrava.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240926088435/en/
IQM Star 24 topology (Photo: Business Wire)
The contract is part of the European High Performance Computing Joint Undertaking (EuroHPC JU) program. This will be the first quantum computer in an HPC centre that will run on IQM´s unique Star Architecture, where 24 qubits are connected to a central resonator. The proprietary star topology QPU is designed to work more efficiently with IQM's latest quantum error correction and other complex algorithms.
Commenting on this announcement, IQM Co-CEO, Mikko Välimäki said: “Winning the first quantum computer delivery in the Czech Republic is a significant milestone for IQM and the entire Central European quantum community. We are extremely excited as this is the first customer system based on our next generation star topology QPU, which is set to shortcut the path to quantum error correction. We are looking forward to working with the IT4Innovations National Supercomputing Centre to push the boundaries of quantum computers further.”
"We are excited to have a quantum computer with the new unique QPU topology. This architecture will significantly improve the efficiency of computations and the scalability of our system. The star topology offers optimal connections between qubits, minimising error rates and increasing the reliability of quantum operations. Thanks to this topology, we can better utilise quantum entanglement and achieve faster and more accurate results in a wide range of applications, from artificial intelligence to complex system simulations," said Branislav Jansík, Supercomputing Services Director at IT4Innovations.
The quantum computer is being built as part of the nine-nation LUMI-Q consortium. It will be available to a wide range of end-users, from the scientific community to industry and the public sector, to actively explore applications and algorithms.
The EuroHPC Joint Undertaking has a budget of around €7 billion for the period 2021-2027 and is funding the procurement of quantum computers for European HPC centres. This will address the growing demand for quantum computing resources from European industry and research institutions, along with the development of a wide range of industrial and scientific applications.
“At IQM, we are proud to be a provider of strategic technology in Europe. Our team has worked hard to make sure that we can deliver on-premises and next-generation quantum computers for high-performance computing centres. This ambitious project will ensure Europe's sovereignty in this critical technology and pave new ways towards efficient error-correction,” said Dr. Jan Goetz, Co-CEO at IQM Quantum Computers.
Read EuroHPC JU and IT4Innovations National Supercomputing Center announcements here: https://eurohpc-ju.europa.eu/advancing-european-quantum-computing-signature-procurement-contract-eurohpc-quantum-computer-located-2024-09-24_en
About IQM Quantum Computers:
IQM is a global leader in designing, building, and selling superconducting quantum computers. IQM provides both on-premises full-stack quantum computers and a cloud platform to access its computers anywhere in the world.
IQM customers include the leading high-performance computing centres, research labs, universities and enterprises which have full access to IQM's software and hardware. IQM has over 280 employees with offices in Espoo, Munich, Paris, Warsaw, Madrid and Singapore.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240926088435/en/
Contacts
Email: press@meetiqm.com
Mobile: +358504790845
www.meetiqm.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmeetiqm.com&es
heet=54127515&newsitemid=20240926088435&lan=en-US&anchor=www.meetiqm.com&index=4
&md5=bbf72ba8baac94eb832480e09cfc6053
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom